A Study of Brodalumab in Subjects With Axial Spondyloarthritis (axSpA)

NCT02985983 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

159

Enrollment

INDUSTRY

Sponsor class

Conditions

Axial Spondyloarthritis

Interventions

DRUG: Brodalumab
DRUG: Placebo

Sponsor

Kyowa Kirin Co., Ltd.